| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.089 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.04 | 0.8 |